Back
Madrigal Pharmaceuticals Vs. Nebius Group NV Industry Stock Comparison
Buy
57
MDGL
Madrigal Pharmaceuticals
Last Price:
319.48
Seasonality Move:
22.96%
Buy
56
NBIS
Nebius Group NV
Last Price:
32.30
Seasonality Move:
-3.07%
Buy
57
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $321.36. The Score for MDGL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Nebius Group NV (NBIS)
is a Buy
Is Nebius Group NV a Buy, Sell or Hold?
- The current Nebius Group NV [NBIS] share price is $29.33. The Score for NBIS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- NBIS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $321.36
The current trend is moderately bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBIS Stock Price Chart
What is Nebius Group NV's stock price today?
-
The Nebius Group NV share price today is $29.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIS is experiencing buying pressure, which is a positive indicator for future bullish movement.
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 16.79 | Buy |
| Relative Strength Index (14 RSI): | 56.73 | Buy |
| Chaikin Money Flow: | 232901 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (280.45 - 351.85) | Buy |
| Bollinger Bands (100): | (217.23 - 303.33) | Buy |
NBIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.49 | Buy |
| Relative Strength Index (14 RSI): | 73.79 | Buy |
| Chaikin Money Flow: | 15634228 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.72 - 23.76) | Buy |
| Bollinger Bands (100): | (17.87 - 21.23) | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 332.27 | Sell |
| 20-day SMA: | 327.98 | Sell |
| 50-day SMA: | 264.31 | Buy |
| 200-day SMA: | 252.87 | Buy |
| 8-day EMA: | 325.99 | Sell |
| 20-day EMA: | 314.81 | Buy |
| 50-day EMA: | 285.4 | Buy |
| 200-day EMA: | 252.19 | Buy |
NBIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.7 | Buy |
| 20-day SMA: | 21.15 | Buy |
| 50-day SMA: | 20.15 | Buy |
| 200-day SMA: | 19.24 | Buy |
| 8-day EMA: | 24.07 | Buy |
| 20-day EMA: | 22.09 | Buy |
| 50-day EMA: | 20.68 | Buy |
| 200-day EMA: | 19.53 | Buy |
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $4.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.16 per share, and an increase next year of $10.02 per share.
Nebius Group NV Earnings Growth & NBIS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Madrigal Pharmaceuticals Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nebius Group NV Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||